D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
SYNH holding history
Syneos Health, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SYNH overviewAll 13F holders of SYNHFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −1,346,898−100.0% | Sold out | Holders |
| Q2 2023 | 1,346,898 | $56.8M | 0.1% | −1,932,876−58.9% | Reduced | Holders |
| Q1 2023 | 3,279,774 | $116.8M | 0.2% | +1,317,919+67.2% | Added | Holders |
| Q4 2022 | 1,961,855 | $72.0M | 0.1% | +1,823,391+1,316.9% | Added | Holders |
| Q3 2022 | 138,464 | $6.53M | <0.1% | +128,740+1,323.9% | Added | Holders |
| Q2 2022 | 9,724 | $697.0K | <0.1% | +9,724 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −3,359−100.0% | Sold out | Holders |
| Q1 2021 | 3,359 | $255.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.